Changes in survival of >3.800 patients with metastatic colorectal cancer in Germany: Results from 16-year prospective longitudinal real-world data analysis 24. Mai 2024 Marschner N, Seufferlein T, Potthoff K, Zahn MO, Uhlig J, Dörfel S, Karcher A, Sauer A, Maintz C, Fruehauf S, Hutzschenreuter U, Tech S, Grafetstätter M, Kruggel L, Jänicke M. ESMO Real World, Volume 4, Issue C, 2024. https://doi.org/10.1016/j.esmorw.2024.100040 Abstract Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data. Marschner N, Knauf W. Oncol Res Treat. 2024 Mar 15:1-11. doi: 10.1159/000536652. Epub ahead of print. Abstract… Weiterlesen Tucatinib in patients with locally advanced or metastatic HER2-positive breast cancer who received at least two prior anti-HER2 treatment regimens: Study design of the non-interventional study TRACE in Germany and Austria Arnd Nusch A, Angerer M, Kreiss-Sender J, Radosa J, Uleer C, Wrobel D, Balic M, Egle D, Harbeck N, Müller V, Schumacher-Wulf E, de Buhr… Weiterlesen